Skip to main content
Premium Trial:

Request an Annual Quote

Report: Athersys Ponders Move to NC

NEW YORK, Nov. 27-Functional genomics company Athersys may pull up its roots in Ohio and move to Durham, N.C., according to a report in the Business Journal of Raleigh/Durham.

In October, the Duke University Institute for Genome Sciences and Policy hired Athersys collaborator and scientific advisor Huntington Willard as its new director, prompting discussions of the move. Willard is currently director and president of the research institute of the University Hospitals of Cleveland.

 

Athersys has about 130 employees, and collaborates with both Case Western Reserve University and the Cleveland Clinic Foundation.

 

The company markets a gene expression tool, RAGE, has developed a gene therapy technique to create artificial human chromosomes, and ultimately plans to develop proteins, peptides, and antibody treatments.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.